FDA issued a Warning Letter to Frontida BioPharm Inc on 8/15/2016 for a previous inspection.
483 Frontida BioPharm Mar 2017

483 Frontida BioPharm Mar 2017

Craig Zagata FDA$119.00 - Available Now

FDA investigators audited the Frontida BioPharm - Philadelphia, PA, United States facility and issued inspectional observations (via FDA 483) on 31 Mar 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 31 Mar 2017
  • Location: Philadelphia, United States
  • FEI: 2523348
Add To Cart